← Leaderboards
Anna E Lokshin
University Of Pittsburgh At Pittsburgh
$15,272,209
Attributed
$21,795,861
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,954,524 · 11
By mechanism
R01$18,229,765 · 6
U54$5,158,663 · 1
U01$2,728,324 · 1
R21$686,272 · 2
R03$151,500 · 1
Top collaborators
- Jon Jacobs8 shared
- Wei-Jun Qian8 shared
- Jennifer K. Barton7 shared
- David A Fishman7 shared
- Robert C Bast5 shared
- Surinder Kumar Batra5 shared
- Randall Brand5 shared
- Steven J Skates3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Surinder Kumar Batra$34,830,369
- Tony E Godfrey$9,226,279
- Rupangi C Vasavada$6,795,197
- Alicia K Au$1,715,557
- Joel L Weissfeld$8,317,064
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingEarly DiagnosisSurvival RateSerumBaseDiagnosisSymptomsDiagnosticBiological MarkersMalignant NeoplasmsValidationTumorSpecificityCohortDetectionPerformanceAlgorithmsMalignant Neoplasm Of OvarySensitivity And SpecificityWomanProspective StudiesProspectiveScreening For Ovarian CancerScreening
Grant awards (55)
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers$755,982
R01 · FY2025 · CA
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer$609,412
R01 · FY2025 · CA · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$526,504
U54 · FY2025 · DA
Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms$725,993
R01 · FY2024 · CA · contact PI
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers$714,585
R01 · FY2024 · CA
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer$584,995
R01 · FY2024 · CA · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$536,927
U54 · FY2024 · DA
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers$61,647
R01 · FY2024 · CA
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers$751,945
R01 · FY2023 · CA
Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms$724,300
R01 · FY2023 · CA · contact PI
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer$622,418
R01 · FY2023 · CA · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$99,799
U54 · FY2023 · DA
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers$62,568
R01 · FY2023 · CA
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers$811,877
R01 · FY2022 · CA
Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms$747,097
R01 · FY2022 · CA · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$678,601
U54 · FY2022 · DA
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer$626,416
R01 · FY2022 · CA · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$500,000
U54 · FY2022 · DA
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers$34,509
R01 · FY2022 · CA
PSP Omics Center of Acute to Chronic Pain Signatures$1,375,166
U54 · FY2021 · DA
Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms$777,101
R01 · FY2021 · CA · contact PI
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer$637,390
R01 · FY2021 · CA · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$1,375,166
U54 · FY2020 · DA
Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms$899,816
R01 · FY2020 · CA · contact PI
PSP Omics Center of Acute to Chronic Pain Signatures$66,500
U54 · FY2019 · DA
Validation of pancreatic cancer biomarkers in large prospective cohorts$417,779
R01 · FY2017 · CA · contact PI
Validation of pancreatic cancer biomarkers in large prospective cohorts$505,275
R01 · FY2016 · CA · contact PI
Validation of pancreatic cancer biomarkers in large prospective cohorts$516,804
R01 · FY2015 · CA · contact PI
Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer$549,452
R01 · FY2014 · CA · contact PI
Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer$534,168
R01 · FY2013 · CA · contact PI
Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer$551,606
R01 · FY2012 · CA · contact PI
Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer$565,354
R01 · FY2011 · CA · contact PI
Development of a multimarker urine-based test for early diagnosis and screening o$191,776
R21 · FY2011 · CA · contact PI
Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer$322,540
R01 · FY2010 · CA · contact PI
Development of a multimarker urine-based test for early diagnosis and screening o$164,756
R21 · FY2010 · CA · contact PI
Multianalyte Assay For Early Diagnosis Of Ovarian Cancer$516,514
R01 · FY2009 · CA · contact PI
Multiplexed Serum Biomarkers for Pancreatic Cancer$439,968
U01 · FY2009 · CA · contact PI
Multianalyte Assay For Early Diagnosis Of Ovarian Cancer$151,448
R01 · FY2009 · CA · contact PI
Prolactin as a risk biomarker of ovarian cancer$75,750
R03 · FY2009 · CA · contact PI
Multiplexed Serum Biomarkers for Pancreatic Cancer$559,273
U01 · FY2008 · CA · contact PI
Multianalyte Assay For Early Diagnosis Of Ovarian Cancer$517,492
R01 · FY2008 · CA · contact PI
Multiplexed Serum Biomarkers for Pancreatic Cancer$151,500
U01 · FY2008 · CA · contact PI
Prolactin as a risk biomarker of ovarian cancer$75,750
R03 · FY2008 · CA · contact PI
Multiplexed Serum Biomarkers for Pancreatic Cancer$557,662
U01 · FY2007 · CA · contact PI
Multianalyte Assay For Early Diagnosis Of Ovarian Cancer$528,564
R01 · FY2007 · CA · contact PI
Multiplexed Serum Biomarkers for Pancreatic Cancer$569,921
U01 · FY2006 · CA · contact PI
Multianalyte Assay For Early Diagnosis Of Ovarian Cancer$543,504
R01 · FY2006 · CA · contact PI
Identification of Early Markers for Ovarian Cancer$322,059
R01 · FY2006 · CA · contact PI
Multianalyte Assay For Early Diagnosis Of Ovarian Cancer$565,965
R01 · FY2005 · CA
Multiplexed Serum Biomarkers for Pancreatic Cancer$450,000
U01 · FY2005 · CA
Identification of Early Markers for Ovarian Cancer$322,882
R01 · FY2005 · CA
Imaging Apoptosis for Chemotherapy Responses$166,388
R21 · FY2005 · CA
Identification of Early Markers for Ovarian Cancer$320,353
R01 · FY2004 · CA
Imaging Apoptosis for Chemotherapy Responses$163,352
R21 · FY2004 · CA
Identification of Early Markers for Ovarian Cancer$329,955
R01 · FY2003 · CA